Detalhe da pesquisa
1.
Five-year follow up of once-daily therapy with emtricitabine, didanosine and efavirenz (Montana ANRS 091 trial).
Antivir Ther
; 12(3): 417-22, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17591032
2.
Impact of HIV-1 reverse transcriptase polymorphism at codons 211 and 228 on virological response to didanosine.
Antivir Ther
; 11(6): 693-9, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-17310813
3.
Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus.
Clin Infect Dis
; 36(8): 1070-3, 2003 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12684922
4.
Restoration of Toxoplasma gondii-specific immune responses in patients with AIDS starting HAART.
AIDS
; 22(16): 2087-96, 2008 Oct 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-18832872
5.
Anal carcinomas in HIV-positive patients: high-dose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy.
Dis Colon Rectum
; 48(6): 1176-81, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15906137
6.
Successful use of darunavir, etravirine, enfuvirtide and tenofovir/emtricitabine in pregnant woman with multiclass HIV resistance.
AIDS
; 23(3): 434-5, 2009 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-19188762
7.
Cholangiocarcinoma in HIV-Infected patients with a history of Cholangitis.
J Acquir Immune Defic Syndr
; 39(2): 253-5, 2005 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15905745